Just reported
From Iradimed's results release of 30 de outubro de 2026; its quarterly report has since been filed.
Actual
US$ 24,2M
+14% y/y
+18% q/q
Guided
—
No guide given
Actual
US$ 0,51
+19% y/y
+24% q/q
Guided
—
No guide given
Actual
US$ 8,1M
+19% y/y
+27% q/q
Guided
—
No guide given
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
The full earnings report →The themes Iradimed is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
As participações na receita são estimativas para nine months ended September 30, 2026, não números de um relatório oficial.
MRidium 3870 MRI-compatible IV infusion pump system
A pump system designed to deliver medicines and fluids in the MRI room. It includes a non-magnetic pump, mobile stand, disposable tubing, and optional remote controls.
MRidium 3860+ MRI-compatible IV infusion pump system
An earlier pump system for delivering medicines and fluids during MRI procedures. IRadimed planned to stop new system sales during 2026 while continuing contracted warranty and technical support.
3880 MRI-compatible patient vital signs monitoring system
A portable monitor that tracks measures such as heart activity, blood oxygen, blood pressure, breathing, and temperature during MRI procedures and patient transport.
3600 ferromagnetic detection system with remote alarm logging unit
Equipment that detects approaching ferromagnetic metal near an MRI room and gives staff a remote screen for viewing alarms and logging items.
MRidium disposable IV tubing sets
Single-use tubing sets that connect the infusion pump to a patient and are made for different types of fluid delivery.
Demonstrações financeiras completas →
IRadimed makes medical equipment that can operate in the powerful magnetic fields around MRI scanners. Its intravenous (IV) pumps deliver medicines and fluids during scans, while its monitors track patients’ vital signs; both are designed to move with patients between hospital departments and the scanner. It also sells equipment that detects ferromagnetic metal near MRI rooms, along with disposable tubing, maintenance agreements, and repair services.
Construído a partir dos próprios documentos de Iradimed Corp. entregues à Comissão de Valores Mobiliários dos EUA (SEC). Os números são os divulgados, com o histórico por ação recalculado para a base de ações de hoje. Isto descreve um negócio — não é recomendação de investimento nem sugestão de compra ou venda.
US$ 85,14-0,2%fechamento 13 de nov.
Números até 30 de setembro de 2026, do 10-Q arquivado em 30 de outubro de 2026
IRadimed sells infusion pumps designed for use beside magnetic resonance imaging (MRI) scanners to hospitals, plus patient monitors and metal detectors.
Grade A+
A faixa sob o preço mostra a nota em cada data, calculada só com os documentos já públicos naquele momento.
Mostrando 2 de 41 trimestres do histórico de notas de Iradimed Corp.. Os outros 39 vão até novembro de 2016.